Works matching IS 18607179 AND DT 2017 AND VI 12 AND IP 15

Results: 9

Recent Research Advances in Selective Matrix Metalloproteinase-13 Inhibitors as Anti-Osteoarthritis Agents.

Published in:

ChemMedChem, 2017, v. 12, n. 15, p. 1157, doi. 10.1002/cmdc.201700349

By:

Xie, Xin‐Wen;
Wan, Ren‐Zhong;
Liu, Zhao‐Peng

Publication type:

Article

A Hollow NaGdF4/AFn Nanosystem Based on 'Relay Race' Release for Therapy.

Published in:

ChemMedChem, 2017, v. 12, n. 15, p. 1191, doi. 10.1002/cmdc.201700295

By:

Zhou, Jie;
Yao, Hanchun;
Meng, Lingchang;
Sun, Chong;
Ye, Weiran;
Du, Qiuzheng

Publication type:

Article

Critical Evaluation of Native Electrospray Ionization Mass Spectrometry for Fragment-Based Screening.

Published in:

ChemMedChem, 2017, v. 12, n. 15, p. 1201, doi. 10.1002/cmdc.201700177

By:

Göth, Melanie;
Badock, Volker;
Weiske, Jörg;
Pagel, Kevin;
Kuropka, Benno

Publication type:

Article

Cover Picture: Discovery of Novel Potent Muscarinic M3 Receptor Antagonists with Proper Plasma Stability by Structural Recombination of Marketed M3 Antagonists (ChemMedChem 15/2017).

Published in:

ChemMedChem, 2017, v. 12, n. 15, p. 1156, doi. 10.1002/cmdc.201700431

By:

Xiang, Zuojuan;
Liu, Jun;
Sun, Hongbin;
Wen, Xiaoan

Publication type:

Article

Design, Synthesis, Pharmacological Evaluation and Docking Studies of GluN2B-Selective NMDA Receptor Antagonists with a Benzo[7]annulen-7-amine Scaffold.

Published in:

ChemMedChem, 2017, v. 12, n. 15, p. 1212, doi. 10.1002/cmdc.201700311

By:

Gawaskar, Sandeep;
Temme, Louisa;
Schreiber, Julian A.;
Schepmann, Dirk;
Bonifazi, Alessandro;
Robaa, Dina;
Sippl, Wolfgang;
Strutz‐Seebohm, Nathalie;
Seebohm, Guiscard;
Wünsch, Bernhard

Publication type:

Article

Comprehensive Analysis of Parasite Biology: From Metabolism to Drug Discovery. Edited by Sylke Müller, Rachel Cerdan and Ovidiu Radulescu; Series Editor: Paul M. Selzer.

Published in:

ChemMedChem, 2017, v. 12, n. 15, p. 1223, doi. 10.1002/cmdc.201700267

By:

Deponte, Marcel

Publication type:

Article

Effects of Pimozide Derivatives on pSTAT5 in K562 Cells.

Published in:

ChemMedChem, 2017, v. 12, n. 15, p. 1183, doi. 10.1002/cmdc.201700234

By:

Rondanin, Riccardo;
Simoni, Daniele;
Maccesi, Martina;
Romagnoli, Romeo;
Grimaudo, Stefania;
Pipitone, Rosaria Maria;
Meli, Maria;
Cascio, Antonio;
Tolomeo, Manlio

Publication type:

Article

Rational Design of a Highly Potent and Selective Peptide Inhibitor of PACE4 by Salt Bridge Interaction with D160 at Position P3.

Published in:

ChemMedChem, 2017, v. 12, n. 15, p. 1169, doi. 10.1002/cmdc.201700300

By:

Dianati, Vahid;
Shamloo, Azar;
Kwiatkowska, Anna;
Desjardins, Roxane;
Soldera, Armand;
Day, Robert;
Dory, Yves L.

Publication type:

Article

Discovery of Novel Potent Muscarinic M3 Receptor Antagonists with Proper Plasma Stability by Structural Recombination of Marketed M3 Antagonists.

Published in:

ChemMedChem, 2017, v. 12, n. 15, p. 1173, doi. 10.1002/cmdc.201700189

By:

Xiang, Zuojuan;
Liu, Jun;
Sun, Hongbin;
Wen, Xiaoan

Publication type:

Article

Works matching IS 18607179 AND DT 2017 AND VI 12 AND IP 15

Recent Research Advances in Selective Matrix Metalloproteinase-13 Inhibitors as Anti-Osteoarthritis Agents.

A Hollow NaGdF<sub>4</sub>/AFn Nanosystem Based on 'Relay Race' Release for Therapy.

Critical Evaluation of Native Electrospray Ionization Mass Spectrometry for Fragment-Based Screening.

Cover Picture: Discovery of Novel Potent Muscarinic M<sub>3</sub> Receptor Antagonists with Proper Plasma Stability by Structural Recombination of Marketed M<sub>3</sub> Antagonists (ChemMedChem 15/2017).

Design, Synthesis, Pharmacological Evaluation and Docking Studies of GluN2B-Selective NMDA Receptor Antagonists with a Benzo[7]annulen-7-amine Scaffold.

Comprehensive Analysis of Parasite Biology: From Metabolism to Drug Discovery. Edited by Sylke Müller, Rachel Cerdan and Ovidiu Radulescu; Series Editor: Paul M. Selzer.

Effects of Pimozide Derivatives on pSTAT5 in K562 Cells.

Rational Design of a Highly Potent and Selective Peptide Inhibitor of PACE4 by Salt Bridge Interaction with D160 at Position P3.

Discovery of Novel Potent Muscarinic M<sub>3</sub> Receptor Antagonists with Proper Plasma Stability by Structural Recombination of Marketed M<sub>3</sub> Antagonists.